Stay Updated
Press Releases
ICYMI: The Price Patients Pay — How High Drug Prices Shape Hispanic and Latino Families' Lives
New report documents how high drug prices shape the lives of Hispanic and Latino families WASHINGTON, D.C. — Last week, Patients For Affordable Drugs released The Price Patients Pay: How Unaffordable Prescription Drugs Shape the Health, Finances, and Daily Lives of Hispanic and Latino Communities alongside We Are Más and Brown University’s Information Futures Lab — a report […]
Press Releases
NEW REPORT: How High Prescription Drug Prices Shape the Lives of Hispanic and Latino Families
WASHINGTON, D.C. — Hispanic and Latino patients are delaying treatment, rationing medication, taking on debt, and traveling abroad to purchase prescription drugs because they cannot afford the high prices charged in the United States, according to a new report released today by Patients For Affordable Drugs, We Are Más, and Brown University’s Information Futures Lab. […]
Press Releases
Patients For Affordable Drugs Reacts to New White House MFN Agreements
WASHINGTON, D.C. — The White House today announced agreements with nine additional pharmaceutical corporations as part of the administration’s Most Favored Nation (MFN) drug pricing strategy. Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB have agreed to provide Medicaid programs access to MFN drug prices on their products. […]
Press Releases
PhRMA’s Medicare Drug Price Negotiation Challenge Rejected by Fifth Circuit U.S. Court of Appeals
Industry’s challenges have now been rejected by the Second, Third, Fifth, and D.C. Circuits. WASHINGTON, D.C. — Yesterday, the U.S. Court of Appeals for the Fifth Circuit rejected a challenge to the Medicare negotiation program brought by Pharmaceutical Research and Manufacturers of America (PhRMA), the National Infusion Center Association, and the Global Colon Cancer Association […]
Press Releases
D.C. Federal Court Rejects Merck’s Challenge To Medicare Drug Price Negotiation
Today’s decision marks the 24th ruling against Big Pharma and in favor of patients. WASHINGTON, D.C. — The U.S. District Court for the District of Columbia rejected Merck’s challenge to the Medicare Drug Price Negotiation Program, handing patients another major legal victory and rejecting another pharmaceutical corporation’s attempt to dismantle the historic program that’s already […]
Press Releases
New video follows three patient advocates as they travel to D.C. to share their stories on Capitol Hill and encourage others to speak up. WASHINGTON, D.C. — August 19, 2026 — Today, on National Patient Advocacy Day, Patients For Affordable Drugs (P4AD) released a new video, Your Voice Is Your Power, celebrating some of the patients whose […]
Press Releases
D.C. Circuit Rejects Teva’s Core Challenges to Medicare Drug Price Negotiation
Patient Advocates Applaud Another Major Legal Victory Protecting Medicare’s Power to Negotiate Lower Drug Prices WASHINGTON, D.C. — The U.S. Court of Appeals for the D.C. Circuit today rejected Teva Pharmaceuticals’ core statutory and constitutional challenges to the Medicare Drug Price Negotiation Program, delivering another significant legal victory for the historic program that is lowering prescription […]
Press Releases
STATEMENT: P4AD Warns Proposed Tariffs On Generic Drugs Would Raise Prices For Patients
WASHINGTON, D.C. — Last night, President Trump announced his plans to instate a 100% tariff on generic drugs beginning in August 2028, with a planned increase up to 200% in 2029, one year after his term ends. According to the president’s Truth Social announcement, the change will not impact brand-name drugs. In response, P4AD CEO […]